V012-7191 Screening compound: N-(2,4-DIFLUOROPHENYL)-N-(2-FLUOROBENZYL)-6-PHENYLTETRAHYDRO-1,3(2H)-PYRIDINEDICARBOXAMIDE

V012-7191 Screening compound: N-(2,4-DIFLUOROPHENYL)-N-(2-FLUOROBENZYL)-6-PHENYLTETRAHYDRO-1,3(2H)-PYRIDINEDICARBOXAMIDE
V012-7191 Screening compound: N-(2,4-DIFLUOROPHENYL)-N-(2-FLUOROBENZYL)-6-PHENYLTETRAHYDRO-1,3(2H)-PYRIDINEDICARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-7191
N-(2,4-DIFLUOROPHENYL)-N-(2-FLUOROBENZYL)-6-PHENYLTETRAHYDRO-1,3(2H)-PYRIDINEDICARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-7191

Molecular Formula

C26H24F3N3O2 (C26 H24 F3 N3 O2)

Compound Name

N-(2,4-DIFLUOROPHENYL)-N-(2-FLUOROBENZYL)-6-PHENYLTETRAHYDRO-1,3(2H)-PYRIDINEDICARBOXAMIDE

IUPAC name

n/a

SMILES

O=C(C(CCC1c2ccccc2)CN1C(Nc(ccc(F)c1)c1F)=O)NCc(cccc1)c1F

InChI

InChI=1S/C26H24F3N3O2/c27-20-11-12-23(22(29)14-20)31-26(34)32-16-19(10-13-24(32)17-6-2-1-3-7-17)25(33)30-15-18-8-4-5-9-21(18)28/h1-9,11-12,14,19,24H,10,13,15-16H2,(H,30,33)(H,31,34)

InChI Key

DAYHBTCYSXRTMF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19898199

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

467.49

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.250

Distribution Coefficient, logD

5.250

Water Solubility, LogSw

-5.30

Polar Surface Area

48.779

Acid Dissociation Constant (pKa)

10.94

Base Dissociation Constant (pKb)

-1.03

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

23.10

V012-7191 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with V012-7191 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-7191?
Check Price and Availability of V012-7191, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-7191 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-7191
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-7191
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-7191 available by request